Variant report
Variant | nsv829208 |
---|---|
Chromosome Location | chr2:49250050-49260907 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs529882535 | chr2:49250054-49250055 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs548343161 | chr2:49250055-49250056 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs569432498 | chr2:49250056-49250057 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs182393088 | chr2:49250067-49250068 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs113416996 | chr2:49250071-49250072 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs377194571 | chr2:49250073-49250074 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs77432855 | chr2:49250146-49250147 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs72877811 | chr2:49250163-49250164 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs551601595 | chr2:49250171-49250172 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs72827267 | chr2:49250184-49250185 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs116743339 | chr2:49250198-49250199 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs148058297 | chr2:49250233-49250234 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs542081526 | chr2:49250258-49250259 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs371332407 | chr2:49250305-49250306 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs115725629 | chr2:49250328-49250329 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs552470218 | chr2:49250345-49250346 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs575819912 | chr2:49250349-49250350 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs77793542 | chr2:49250366-49250367 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs564568253 | chr2:49250384-49250385 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs72827268 | chr2:49250419-49250420 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs150012914 | chr2:49250463-49250464 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs559417262 | chr2:49250537-49250538 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs529972178 | chr2:49250544-49250545 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs548098406 | chr2:49250546-49250547 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs113155106 | chr2:49250576-49250577 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs72827270 | chr2:49250623-49250624 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs140155484 | chr2:49250638-49250639 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs190936902 | chr2:49250655-49250656 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs570200375 | chr2:49250658-49250659 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs553257670 | chr2:49250719-49250720 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs113271420 | chr2:49250723-49250724 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs536984279 | chr2:49250740-49250741 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs546551466 | chr2:49250799-49250800 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs568676666 | chr2:49250819-49250820 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs12713033 | chr2:49250821-49250822 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
36 | rs12713034 | chr2:49250971-49250972 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
37 | rs575959286 | chr2:49250988-49250989 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs72827271 | chr2:49250994-49250995 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs74654739 | chr2:49251056-49251057 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs573353895 | chr2:49251061-49251062 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs540288655 | chr2:49251067-49251068 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs573049088 | chr2:49251081-49251082 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs562078558 | chr2:49251117-49251118 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs556852079 | chr2:49251122-49251123 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs574653104 | chr2:49251165-49251166 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs182449828 | chr2:49251169-49251170 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs143892102 | chr2:49251199-49251200 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs575419911 | chr2:49251226-49251227 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs530656483 | chr2:49251241-49251242 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs146888963 | chr2:49251250-49251251 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Bladder cancer | 21909424 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 17297452 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 20433910 | CNVD |
Autism | 21701786 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 20553308 | CNVD |
Autism | 22241247 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Mental retardation | 19521722 | CNVD |
Schizophrenia | 18990708 | CNVD |
Schizophrenia | 18940311 | CNVD |
Schizophrenia | 19348701 | CNVD |
Schizophrenia | 18945720 | CNVD |
Schizophrenia | 19571808 | CNVD |
Prostate cancer | 16573809 | CNVD |
Neuroticism | 17667963 | CNVD |
Schizophrenia | 19443537 | CNVD |
Schizophrenia | 19546859 | CNVD |
Autism | 17322880 | CNVD |
Lung cancer | 17086460 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
T-cell lymphomas | 22341440 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:49245600-49256600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr2:49249000-49253800 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
3 | chr2:49251800-49252400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr2:49251800-49252400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
5 | chr2:49251800-49252400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
6 | chr2:49252000-49253200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
7 | chr2:49252400-49256400 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr2:49253200-49256600 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
9 | chr2:49254000-49255000 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
10 | chr2:49255200-49255400 | Enhancers | Brain Germinal Matrix | brain |
11 | chr2:49255200-49255400 | Enhancers | Pancreatic Islets | Pancreatic Islet |
12 | chr2:49255400-49256400 | Weak transcription | Brain Germinal Matrix | brain |
13 | chr2:49256000-49257200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
14 | chr2:49256400-49257000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
15 | chr2:49256400-49261600 | Enhancers | Brain Germinal Matrix | brain |
16 | chr2:49256600-49256800 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
17 | chr2:49256600-49257200 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
18 | chr2:49256800-49257400 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
19 | chr2:49257000-49260400 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
20 | chr2:49259200-49261200 | Enhancers | Fetal Brain Male | brain |
21 | chr2:49260200-49260400 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
22 | chr2:49260400-49260600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
23 | chr2:49260400-49261000 | Enhancers | Fetal Brain Female | brain |